# PROGESTERONE
> **ANDA215634** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2022-01-05
## Drug
- **FDA Application Number:** ANDA215634
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PROGESTERONE
- **Generic name:** PROGESTERONE
- **Active ingredients:** PROGESTERONE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** XIROMED, LLC
- **First approval:** 2022-01-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215634)
---
*AI Analytics · CC0 1.0*